Mar 27, 2023

Suraj Mudichintala is a Senior Associate at Action Potential Capital which is GSK's bioelectronic medicine venture fund.

Top 3 Takeaways:

• "Our fund is different in that we invest actually directly off of GSK's balance sheet. So we're what's called an evergreen fund where we don't actually have a fund size"
• "The way that I think about it is that a VC is really paid to allocate capital but really is really paid to think. You really have to think about what is the next space or the next technology that could disrupt a space? And because of that, it's a much you often have to take a much more longitudinal view. And it takes a lot of patience and tracking a space oftentimes for years"
• "When you reach out to a VC having a pitch, first of all, sending a non-confidential pitch deck is mandatory, I think. And that deck is essentially where we're making the first decision as to whether or not to do a call with you"

0:45 Do you want to introduce yourself better than I just did?

1:15 "Do you wanna talk about Action Potential, what it is, who it was formed by, and the investment thesis?"

2:30 Do you want to talk about the expansion of the AP investment thesis?

4:30 What does traditional Venture Capital look like and how is it different in that you are funded by GSK?

6:15 What do the positions within a VC firm look like?

7:45 How has it been for you going from Analyst to Associate?

8:45 What does your due diligence look like?

11:45 "A lot of VCs have a target size range, be it seed or angel or, maybe larger institutional stuff. But it sounds like you guys don't really have that?"

12:45 "How did you get into this space?"

14:45 "So how does consulting compare to the VC life?"

18:45 "What would you suggest is the best way to get your attention?"

24:00 What are some tips and tricks to reaching out to you?

27:00 What was the worst pitch deck you ever saw?

28:30 " Is there anything that we didn't talk about that you wanted to mention?"